AOU
Desconocido
BEAt-DKD: Biomarker Enterprise to Attack DKD Sofia ref. 115974
AZIENDA OSPEDALIERO UNIVERSITARIA CONSORZIALE POLICLINICO DI BARI
participó en un
H2020:
H2020-JTI-IMI2-2015-05-two-stage
Diabetic kidney disease (DKD) is the leading cause of end stage renal disease (ESRD), and its global incidence and prevalence have reached e...
2016-12-20 - 2023-08-31 | Financiado
2016-12-20 - 2023-08-31 | Financiado
GAPP: GAbapentin in Paediatric Pain
AZIENDA OSPEDALIERO UNIVERSITARIA CONSORZIALE POLICLINICO DI BARI
participó en un
FP7:
Chronic pain is estimated to affect 15-20% of children with varying disabilities. Due to the paucity of clinical information and appropriate...
Financiado
Financiado
DEEP: DEferiprone Evaluation in Paediatrics
AZIENDA OSPEDALIERO UNIVERSITARIA CONSORZIALE POLICLINICO DI BARI
participó en un
FP7:
β-thalassaemia major is one of the most severe forms of chronic congenital anaemia. The recommended treatment consists in regular blood tran...
Financiado
Financiado
* No se disponen de datos de la empresa actual.